TTK Healthcare Limited (BOM:507747)

Market Cap	12.45B -26.5%
Revenue (ttm)	8.57B +7.0%
Net Income	656.81M -19.6%
EPS	46.48 -19.6%
Shares Out	14.13M
PE Ratio	18.96
Forward PE	n/a
Dividend	10.00 (1.12%)
Ex-Dividend Date	Jul 17, 2026

Volume	152
Open	880.05
Previous Close	889.90
Day's Range	859.20 - 901.45
52-Week Range	737.00 - 1,402.00
Beta	0.27
Analysts	Strong Buy
Price Target	1,020.00 (+15.77%)
Earnings Date	May 30, 2026

About TTK Healthcare

TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment...

• Industry: Pharmaceutical Preparations
• Founded: 1928
• Employees: 1,339
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 507747

Financial Performance

In fiscal year 2026, TTK Healthcare's revenue was 8.57 billion, an increase of 6.96% compared to the previous year's 8.01 billion. Earnings were 656.81 million, a decrease of -19.57%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 17, 2026

Data Sources Report a data error